Philip Lister
- Molecular Medicine top 0.1%
- Molecular Biology top 10%
- Pharmacology top 1%
- Epidemiology top 5%
- Applied Microbiology and Biotechnology top 0.5%
- Co-authors
- Daniel J. WolterNancy D. HansonChristine C. SandersLaurel C. PreheimMartha J. GentryJ. Michael JandaRichard V. GoeringAnnpey Pong
- Topics
- Antibiotic Resistance in Bacteria (30 papers)Antibiotics Pharmacokinetics and Efficacy (21 papers)Pneumonia and Respiratory Infections (10 papers)
- Partner nations
- United StatesUnited KingdomChina
In The Last Decade
Philip Lister
47 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Molecular Medicine 1.7k
- Molecular Biology 985
- Pharmacology 853
- Epidemiology 591
- Applied Microbiology and Biotechnology 368
Countries citing papers authored by Philip Lister
This map shows the geographic impact of Philip Lister's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Lister with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Lister more than expected).
Fields of papers citing papers by Philip Lister
This network shows the impact of papers produced by Philip Lister. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Lister. The network helps show where Philip Lister may publish in the future.
Co-authorship network of co-authors of Philip Lister
This figure shows the co-authorship network connecting the top 25 collaborators of Philip Lister. A scholar is included among the top collaborators of Philip Lister based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Lister. Philip Lister is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 4 | |
| 3 | 64 | |
| 4 | 33 | |
| 5 | 29 | |
| 6 | 29 | |
| 7 | 39 | |
| 8 | 15 | |
| 9 | 59 | |
| 10 | 20 | |
| 11 | 38 | |
| 12 | 49 | |
| 13 | 25 | |
| 14 | 67 | |
| 15 | 120 | |
| 16 | 30 | |
| 17 | 39 | |
| 18 | 32 | |
| 19 | 27 | |
| 20 | 23 |
About Philip Lister
Philip Lister is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Pharmacology, having authored 50 papers that have together received 2.6k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (30 papers), Antibiotics Pharmacokinetics and Efficacy (21 papers) and Pneumonia and Respiratory Infections (10 papers). The work is most often cited by research in Molecular Medicine (1.7k citations), Applied Microbiology and Biotechnology (368 citations) and Endocrinology (306 citations). Philip Lister has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Daniel J. Wolter, Nancy D. Hanson, Christine C. Sanders, Laurel C. Preheim, Martha J. Gentry, J. Michael Janda, Richard V. Goering, Annpey Pong, Stephen A. Chartrand and William E. Sanders. Their work appears in journals such as Clinical Microbiology Reviews, Clinical Infectious Diseases and Journal of Clinical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.